Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Project honeybee: Clinical applications for wearable biosensors.

Hartwell L, Ross HM, La Belle JT.

Biomed Microdevices. 2019 Apr 1;21(2):37. doi: 10.1007/s10544-019-0392-y.

PMID:
30937547
2.

Experience participating in the American College of Cardiology Quality NetworkTM: paediatric and adult congenital cardiology collaborative quality improvement.

Hartwell LP, Baker AL, Jenkins KJ, de Ferranti SD, Saleeb SF.

Cardiol Young. 2019 Jan;29(1):59-66. doi: 10.1017/S104795111800183X. Epub 2018 Oct 30.

PMID:
30375299
3.

Perspectives on symptom experiences and symptom reporting among individuals on hemodialysis.

Flythe JE, Dorough A, Narendra JH, Forfang D, Hartwell L, Abdel-Rahman E.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1842-1852. doi: 10.1093/ndt/gfy069.

PMID:
29672712
4.

Responsive Designed Interventions Are Needed to Support Positive Outcomes of Children and Adolescents with CKD.

Hartwell LM.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):357-358. doi: 10.2215/CJN.00990118. Epub 2018 Feb 22. No abstract available.

5.

Management of Opioid and Sedative Weaning in Pediatric Congenital Heart Disease Patients: Assessing the State of Practice.

O'Connell C, Ziniel S, Hartwell L, Connor J.

Dimens Crit Care Nurs. 2017 Mar/Apr;36(2):116-124. doi: 10.1097/DCC.0000000000000229.

PMID:
28151790
6.

Reply to Galvão-Moreira and da Cruz: Saliva biomarkers to complement the visualization-based oral cancer detection.

Hartwell LH.

Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E111. doi: 10.1073/pnas.1618154114. Epub 2016 Dec 30. No abstract available.

7.

Understanding Dialysis Patient Perspectives on Advocacy.

Hartwell L.

Am J Kidney Dis. 2017 Jan;69(1):5-7. doi: 10.1053/j.ajkd.2016.10.002. No abstract available.

PMID:
28007192
8.

Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.

Yu JS, Chen YT, Chiang WF, Hsiao YC, Chu LJ, See LC, Wu CS, Tu HT, Chen HW, Chen CC, Liao WC, Chang YT, Wu CC, Lin CY, Liu SY, Chiou ST, Chia SL, Chang KP, Chien CY, Chang SW, Chang CJ, Young JD, Pao CC, Chang YS, Hartwell LH.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11549-11554. Epub 2016 Sep 23. Erratum in: Proc Natl Acad Sci U S A. 2016 Oct 24;:.

9.

Patient and Other Stakeholder Engagement in Patient-Centered Outcomes Research Institute Funded Studies of Patients with Kidney Diseases.

Cukor D, Cohen LM, Cope EL, Ghahramani N, Hedayati SS, Hynes DM, Shah VO, Tentori F, Unruh M, Bobelu J, Cohen S, Dember LM, Faber T, Fischer MJ, Gallardo R, Germain MJ, Ghahate D, Grote N, Hartwell L, Heagerty P, Kimmel PL, Kutner N, Lawson S, Marr L, Nelson RG, Porter AC, Sandy P, Struminger BB, Subramanian L, Weisbord S, Young B, Mehrotra R.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1703-12. doi: 10.2215/CJN.09780915. Epub 2016 May 19. Review.

10.

Be proactive about monitoring your potassium.

Hartwell L.

Nephrol News Issues. 2015 May;29(5):41-3. No abstract available.

PMID:
26197699
11.

What every renal care professional should know about transplantation.

Hartwell L.

Nephrol News Issues. 2014 Dec;28(13):25-6. No abstract available.

PMID:
26020083
12.

Acute fatty liver of pregnancy treated with plasma exchange.

Hartwell L, Ma T.

Dig Dis Sci. 2014 Sep;59(9):2076-80. doi: 10.1007/s10620-014-3328-7. No abstract available.

PMID:
25138903
13.

The Renal Support Network, 20 years later.

Hartwell L.

Nephrol News Issues. 2013 Dec;27(13):13. No abstract available.

PMID:
24597064
14.

Development of an outcome measure to monitor the effectiveness of pain management.

Mantell P, Hartwell LP, Branowicki PA.

Clin J Oncol Nurs. 2014 Feb;18(1):30-2. doi: 10.1188/14.CJON.30-32.

PMID:
24476723
15.

Transplantation: what every patient and health care professional should know.

Hartwell L.

Nephrol News Issues. 2013 Aug;27(9):28-9. No abstract available.

PMID:
24133843
16.

Why support groups provide help and hope.

Hartwell L.

Nephrol News Issues. 2012 Aug;26(9):30, 32. No abstract available.

PMID:
23252079
17.

I want to be at least a 10: the impact of changes in metrics and labeling for ESAs.

Hartwell L.

Nephrol News Issues. 2012 Jun;26(7):12-3. No abstract available.

PMID:
22928240
18.

Guideline adherence and outcomes in esophageal variceal hemorrhage: comparison of tertiary care and non-tertiary care settings.

Schlansky B, Lee B, Hartwell L, Urquhart J, Willis B, Zaman A.

J Clin Gastroenterol. 2012 Mar;46(3):235-42. doi: 10.1097/MCG.0b013e318227422d.

PMID:
21778893
19.

Patient engagement: reality or annoyance?

Hartwell L.

Nephrol News Issues. 2010 Aug;24(9):37-8. No abstract available.

PMID:
20865962
20.

Who lives? (We all do now--but it wasn't always that way).

Hartwell L.

Nephrol News Issues. 2009 Aug;23(9):12-4. No abstract available.

PMID:
19753928
21.

Join the PEPP rally: program combines experience and education to help empower the community.

Hartwell L.

Nephrol News Issues. 2008 Aug;22(9):46. No abstract available.

PMID:
18778006
22.

Management of mineral and bone disorders in patients on dialysis: a team approach to improving outcomes.

Carver M, Carder J, Hartwell L, Arjomand M.

Nephrol Nurs J. 2008 May-Jun;35(3):265-70. Review.

PMID:
18649587
23.

Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.

Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A, Greinix H; Quality Assurance and Clinical Working Groups of the World Marrow Donor Association.

Bone Marrow Transplant. 2008 Jul;42(1):9-14. doi: 10.1038/bmt.2008.76. Epub 2008 Mar 24.

PMID:
18362904
24.

Biomarkers. 'I'm pretty Optimistic'.

Hartwell L.

Newsweek. 2006 Dec 11;148(24):61. No abstract available.

PMID:
17186886
25.

Cancer biomarkers: a systems approach.

Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E.

Nat Biotechnol. 2006 Aug;24(8):905-8. Review. No abstract available.

PMID:
16900126
26.

Two trees in the forest: a patient's perception of quality of life.

Hartwell L.

Nephrol News Issues. 2006 Jul;20(8):72-3. No abstract available.

PMID:
16859236
27.

Adding a little more 'PEPP' to the renal community.

Hartwell L.

Nephrol News Issues. 2006 Jan;20(1):33. No abstract available.

PMID:
16438435
28.

Yeast and cancer.

Hartwell LH.

Biosci Rep. 2004 Aug-Oct;24(4-5):523-44.

PMID:
16134024
29.

Perspective: a program to improve protein biomarker discovery for cancer.

Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R.

J Proteome Res. 2005 Jul-Aug;4(4):1104-9.

PMID:
16083259
30.

Genetics. Robust interactions.

Hartwell L.

Science. 2004 Feb 6;303(5659):774-5. No abstract available.

PMID:
14764857
31.

Patients educating patients. Let's add a little PEP to the renal community.

Hartwell L.

Nephrol News Issues. 2003 Sep;17(10):67. No abstract available.

PMID:
14533518
32.

Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.

Rosenmayr A, Hartwell L, Egeland T; Ethics Working Group of the World Marrow Donor Association.

Bone Marrow Transplant. 2003 Apr;31(7):539-45.

PMID:
12692618
33.

The case for early detection.

Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L.

Nat Rev Cancer. 2003 Apr;3(4):243-52. Review.

PMID:
12671663
34.

Nobel Lecture. Yeast and cancer.

Hartwell LH.

Biosci Rep. 2002 Jun-Aug;22(3-4):373-94.

PMID:
12516780
35.

Cancer centre didn't shoot the messenger.

Hartwell L.

Nature. 2002 Apr 25;416(6883):785. No abstract available.

PMID:
11976648
36.

Interview: Leland Hartwell, PhD, Nobel Prize for Medicine winner.

Hartwell L.

MedGenMed. 2001 Oct 18;3(4):3. No abstract available.

37.

Principles for the buffering of genetic variation.

Hartman JL 4th, Garvik B, Hartwell L.

Science. 2001 Feb 9;291(5506):1001-4. Review. No abstract available.

PMID:
11232561
38.

Triplet energies of pi-conjugated polymers.

Monkman AP, Burrows HD, Hartwell LJ, Horsburgh LE, Hamblett I, Navaratnam S.

Phys Rev Lett. 2001 Feb 12;86(7):1358-61.

PMID:
11178083
39.

Dynamic interaction of DNA damage checkpoint protein Rad53 with chromatin assembly factor Asf1.

Emili A, Schieltz DM, Yates JR 3rd, Hartwell LH.

Mol Cell. 2001 Jan;7(1):13-20.

40.

Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.

Simon JA, Szankasi P, Nguyen DK, Ludlow C, Dunstan HM, Roberts CJ, Jensen EL, Hartwell LH, Friend SH.

Cancer Res. 2000 Jan 15;60(2):328-33.

41.

From molecular to modular cell biology.

Hartwell LH, Hopfield JJ, Leibler S, Murray AW.

Nature. 1999 Dec 2;402(6761 Suppl):C47-52.

PMID:
10591225
42.

Drug target validation and identification of secondary drug target effects using DNA microarrays.

Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE Jr, Hartwell LH, Brown PO, Friend SH.

Nat Med. 1998 Nov;4(11):1293-301.

PMID:
9809554
43.

Understanding the cell cycle.

Nurse P, Masui Y, Hartwell L.

Nat Med. 1998 Oct;4(10):1103-6. No abstract available.

PMID:
9771732
45.

Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.

Kline GH, Hartwell L, Beck-Engeser GB, Keyna U, Zaharevitz S, Klinman NR, Jäck HM.

J Immunol. 1998 Aug 15;161(4):1608-18.

46.

Genomics and human disease--variations on variation.

Brown PO, Hartwell L.

Nat Genet. 1998 Feb;18(2):91-3. No abstract available.

PMID:
9462728
47.

Integrating genetic approaches into the discovery of anticancer drugs.

Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH.

Science. 1997 Nov 7;278(5340):1064-8. Review.

PMID:
9353181
48.

Eighth Annual Pezcoller Symposium: genomic instability and immortality in cancer.

Mihich E, Hartwell L.

Cancer Res. 1997 Oct 1;57(19):4437-41. No abstract available.

49.

CDC5 and CKII control adaptation to the yeast DNA damage checkpoint.

Toczyski DP, Galgoczy DJ, Hartwell LH.

Cell. 1997 Sep 19;90(6):1097-106.

Supplemental Content

Loading ...
Support Center